Palmitoylation Dynamics in Systemic Lupus Erythematosus: Multi‐Omics Insights and Potential Therapeutic Implications
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70346 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Zeyu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Medicine, Wenzhou Medical University, Zhejiang, China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lipoylation. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Objective
Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by immune dysregulation. The role of palmitoylation in regulating immune responses and its contribution to SLE pathogenesis remains insufficiently understood.
Methods
We conducted a multi‐omics analysis using the GSE61635 dataset to identify differentially expressed genes (DEGs) in SLE. Palmitoylation‐related genes (PRGs) were identified through differential expression analysis, weighted gene co‐expression network analysis (WGCNA), and machine learning models. Single‐cell RNA sequencing (scRNA‐seq) was used to assess immune cell dynamics, and Mendelian randomization (MR) was employed to explore causal relationships between metabolites and SLE.
Results
We identified 3946 DEGs and 13 key PRGs associated with palmitoylation in SLE. Four hub genes (ACSL1, ZDHHC12, GPX1, and DDHD2) were highlighted as potential biomarkers. Functional enrichment analysis revealed that these genes are involved in fatty acid metabolism and immune signaling. scRNA‐seq analysis showed increased palmitoylation activity in neutrophils and cytotoxic T lymphocytes (CTLs) in SLE. MR analysis identified four phospholipids containing palmitic acid as causally linked to SLE.
Conclusion
This study identifies ACSL1 and ZDHHC12 as potential therapeutic targets for modulating palmitoylation and immune responses in SLE. Further research is required to validate these findings and explore their clinical implications for SLE treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Medicine, Wenzhou Medical University, Zhejiang, China.
- School of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Zhejiang, China.
- School of Basic Medical Sciences, Wenzhou Medical University, Zhejiang, China.
- Laboratory Animal Center, Wenzhou Medical University, Zhejiang, China.
ORCID-Profile: Yanggang Hong, Sheng Gao
Zitieren
APA
Liu, Z., Hong, Y., Hua, G., Li, Z., Hua, C., & Gao, S. (2025). Palmitoylation Dynamics in Systemic Lupus Erythematosus: Multi‐Omics Insights and Potential Therapeutic Implications. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70346
Vancouver
Liu Z, Hong Y, Hua G, Li Z, Hua C, Gao S. Palmitoylation Dynamics in Systemic Lupus Erythematosus: Multi‐Omics Insights and Potential Therapeutic Implications. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70346
BibTeX
@article{Liu2025,
author = {Liu, Zeyu and Hong, Yanggang and Hua, Guo and Li, Zixi and Hua, Chunyan and Gao, Sheng},
title = {Palmitoylation Dynamics in Systemic Lupus Erythematosus: Multi‐Omics Insights and Potential Therapeutic Implications},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70346}
}
EUVIMED